ExLibris header image
SFX Logo
Title: Discovery of novel pyrazolopyrimidinone analogs as potent inhibitors of phosphodiesterase type-5
Source:

Bioorganic & Medicinal Chemistry [0968-0896] Sawant, Sanghapal yr:2015


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Kotera, J. "Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction." The Journal of urology 188.2 (2012): 668-674. Link to SFX for this item
2. Hellstrom, Wayne J G J. "Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study." The Journal of urology 194.2 (2015): 485-492. Link to SFX for this item
3. Kessler, Liang M. "Phosphodiesterase 5 Inhibitors for the Treatment of Erectile Dysfunction: A Trade-off Network Meta-analysis." European urology 68.4 (2015): 674-80. Link to SFX for this item
4. Younes, A. "A bioluminescence method for direct measurement of phosphodiesterase activity." Analytical biochemistry 417.1 (2011): 36-40. Link to SFX for this item
5. Rotella, David P P. "Phosphodiesterase 5 inhibitors: current status and potential applications." Nature reviews. Drug discovery 1.9 (2002): 674-82. Link to Full Text for this item Link to SFX for this item
6. Zhao, C. "Efficacy and safety of avanafil for treating erectile dysfunction: results of a multicentre, randomized, double‐blind, placebo‐controlled trial." BJU international 110.11 (2012): 1801-1806. Link to Full Text for this item Link to SFX for this item
7. Goldstein, I. "Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus." Mayo Clinic proceedings 87.9 (2012): 843-852. Link to Full Text for this item Link to SFX for this item
8. Roegler, C. "[Medicinal chemistry of nitrates and PDE5 inhibitors]." Pharmazie in unserer Zeit 39.5 (2010): 351-358. Link to Full Text for this item Link to SFX for this item
9. Goldstein, I. "A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction." The journal of sexual medicine 9.4 (2012): 1122-1133. Link to SFX for this item
10. Palit, V. "An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction." Nature reviews. Urology 7.11 (2010): 603-609. Link to SFX for this item
11. Ding, P. "The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter." PLoS ONE 6.4 (2011). Link to Full Text for this item Link to SFX for this item
12. Birch, David G G. "A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration." American journal of ophthalmology 133.5 (2002): 665-72. Link to SFX for this item
13. Choi, S. "Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers." Clinical therapeutics 32.6 (2010): 1178-1187. Link to SFX for this item
14. Zhang, D. "Carboxyamidotriazole: A novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases." European journal of pharmacology 746 (2015): 14-21. Link to SFX for this item
15. Smith, W. B. B. "PDE5 inhibitors: considerations for preference and long-term adherence." International journal of clinical practice 67.8 (2013): 768-780. Link to Full Text for this item Link to SFX for this item
16. Kim, Ki Y. "Discovery of new inhibitor for PDE3 by virtual screening." Bioorganic and medicinal chemistry letters 21.6 (2011): 1617-1620. Link to SFX for this item
17. Mulhall, John P. "A Phase 3, Placebo-Controlled Study of the Safety and Efficacy of Avanafil for the Treatment of Erectile Dysfunction Following Nerve-Sparing Radical Prostatectomy." The Journal of urology 189.6 (2012): 2229-2236. Link to SFX for this item
18. Josephson, Michael R. "Ca2+-dependent components of inactivation of unitary cardiac L-type Ca2+channels." Journal of physiology 588.1 (2010): 213-223. Link to Full Text for this item Link to SFX for this item
19. Albersen, M. "Evaluation and treatment of erectile dysfunction in the aging male: a mini-review." Gerontology 58.1 (2012): 3-14. Link to SFX for this item
20. Fudala, R. "Fluorescence detection of hyaluronidase." Journal of photochemistry and photobiology. B, Biology 104.3 (2011): 473-477. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced